Circulation · 1992 · 21 citations · 16 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyElectrophysiologyPharmacodynamicsAntiarrhythmic TherapyArrhythmia PharmacotherapyCardiac Ion ChannelsIon Channel PharmacologyIon Channel PhysiologyVentricular ElectrophysiologyAntiarrhythmic Drug EffectsAntiarrhythmic MedicationsConduction Velocity AnalysisConduction Velocity ModulationMultielectrode Array AnalysisMultielectrode Array TechnologySodium Channel PharmacologySodium Channel Physiology
BACKGROUND: Arrhythmias resulting from treatment with sodium channel-blocking antiarrhythmic drugs have been successfully treated with sodium infusion, although the mechanism underlying this effect is uncertain. METHODS AND RESULTS: In this study, we used a multielectrode array to examine the effects of O-desmethyl encainide (ODE), a potent sodium channel-blocking metabolite of encainide, on conduction in canine ventricle. ODE depressed both longitudinal and transverse conduction velocities in a plasma concentration-related fashion (r = -0.74, -0.60; p less than 0.001). At ODE concentrations less than or equal to 300 ng/ml (n = 34), conduction velocity was depressed to the same extent in the longitudinal (-21.9 +/- 8.4%, SD) and transverse orientations (-22.0 +/- 8.8%). However, at concentrations greater than 300 ng/ml (n = 17), conduction was significantly more impaired longitudinally than transversely (-44.5 +/- 11.7% versus -34.4 +/- 13.7%, p less than 0.02). In 12 animals with high concentrations (mean, 432 +/- 32 ng/ml), a 5-meq/kg bolus of sodium chloride over 1 minute immediately increased conduction velocity; this effect was significantly greater and longer lasting in the longitudinal orientation. In two animals, conduction block in the longitudinal orientation was documented at high plasma ODE and was immediately reversed by sodium bolus. CONCLUSIONS: We conclude that the major effect of sodium in animals with excess sodium channel block is improvement of longitudinal propagation; this effect may underlie the antiarrhythmic action of sodium in the analogous clinical setting.
16
Malignant ventricular tachyarrhythmias associated with the use of encainide
Roger A. Winkle, Jay W. Mason, Jerry C. Griffin et al. · American Heart Journal · 1981 · 213 citations